ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 205.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,417,000 | -42.7% | 367,200 | 0.0% | 0.13% | -43.5% |
| Q4 2014 | $2,471,000 | +22.6% | 367,200 | 0.0% | 0.24% | +13.9% |
| Q3 2014 | $2,016,000 | -46.4% | 367,200 | 0.0% | 0.21% | -35.6% |
| Q2 2014 | $3,764,000 | -14.6% | 367,200 | 0.0% | 0.32% | -10.3% |
| Q1 2014 | $4,410,000 | +6.2% | 367,200 | 0.0% | 0.36% | +5.6% |
| Q4 2013 | $4,153,000 | – | 367,200 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,408,728 | $17,037,000 | 0.97% |
| WealthTrust Axiom LLC | 140,000 | $441,000 | 0.16% |
| Palo Alto Investors LP | 1,032,715 | $3,253,000 | 0.15% |
| SHEPHERD KAPLAN KROCHUK, LLC | 49,761 | $157,000 | 0.08% |
| Joel Isaacson & Co., LLC | 80,660 | $254,000 | 0.05% |
| Malaga Cove Capital, LLC | 10,250 | $31,000 | 0.02% |
| Cornerstone Capital, Inc. | 30,000 | $95,000 | 0.02% |
| Granahan Investment Management | 31,298 | $99,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,150 | $769,000 | 0.01% |
| Advisor Group, Inc. | 117,657 | $371,000 | 0.01% |